Inflammatory Bowel Diseases

Cover image for Inflammatory Bowel Diseases

February 2001

Volume 7, Issue 1

Pages 1–81

  1. Original Contributions

    1. Top of page
    2. Original Contributions
    3. Case Reports
    4. Basic Science Reviews
    5. Review Articles
    6. Controversies in IBD
    7. Section Editor's Commentary
    8. Clinical Viewpoints
    9. Section Editor's Commentary
    10. Basic Science on the Cutting Edge
    11. Selected Summaries
    1. Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease (pages 1–7)

      Dr. Sonia Friedman, James F. Marion, Ellen Scherl, Peter H. Rubin and Daniel H. Present

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200102000-00001

    2. Anti-Saccharomyces Cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: A study in IBD families (pages 8–15)

      Severine Vermeire, Marc Peeters, Robert Vlietinck, Sofie Joossens, Elly Den Hond, Veerle Bulteel, Xavier Bossuyt, Benny Geypens and Prof. Dr. Paul Rutgeerts

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200102000-00002

    3. Inflammation location, but not type, determines the increase in TGF-β1 and IGF-1 expression and collagen deposition in IBD intestine (pages 16–26)

      Dr. Ian Craig Lawrance, Lesley Maxwell and William Doe

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200102000-00003

    4. A clustering of Crohn's disease in Mankato, Minnesota (pages 27–33)

      Dr. Herbert J. Van Kruiningen and Benjamin J. Freda

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200102000-00004

  2. Case Reports

    1. Top of page
    2. Original Contributions
    3. Case Reports
    4. Basic Science Reviews
    5. Review Articles
    6. Controversies in IBD
    7. Section Editor's Commentary
    8. Clinical Viewpoints
    9. Section Editor's Commentary
    10. Basic Science on the Cutting Edge
    11. Selected Summaries
    1. Successful desensitization and therapeutic use of infliximab in adult and pediatric Crohn's disease patients with prior anaphylactic reaction (pages 34–37)

      Thomas C. Puchner, Subra Kugathasan, Kevin J. Kelly and Dr. David G. Binion

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200102000-00005

    2. Infliximab for the treatment of orofacial Crohn's disease (pages 38–42)

      Uma Mahadevan and Dr. William J. Sandborn

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200102000-00006

  3. Basic Science Reviews

    1. Top of page
    2. Original Contributions
    3. Case Reports
    4. Basic Science Reviews
    5. Review Articles
    6. Controversies in IBD
    7. Section Editor's Commentary
    8. Clinical Viewpoints
    9. Section Editor's Commentary
    10. Basic Science on the Cutting Edge
    11. Selected Summaries
    1. Paneth cell defensins and innate immunity of the small bowel (pages 43–50)

      Dr. Andre J. Ouellette and Dr. Charles L. Bevins

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200102000-00007

  4. Review Articles

    1. Top of page
    2. Original Contributions
    3. Case Reports
    4. Basic Science Reviews
    5. Review Articles
    6. Controversies in IBD
    7. Section Editor's Commentary
    8. Clinical Viewpoints
    9. Section Editor's Commentary
    10. Basic Science on the Cutting Edge
    11. Selected Summaries
    1. Measles virus and Crohn's disease: A critical appraisal of the current literature (pages 51–57)

      Dr. Douglas J. Robertson and Robert S. Sandler

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200102000-00008

  5. Controversies in IBD

    1. Top of page
    2. Original Contributions
    3. Case Reports
    4. Basic Science Reviews
    5. Review Articles
    6. Controversies in IBD
    7. Section Editor's Commentary
    8. Clinical Viewpoints
    9. Section Editor's Commentary
    10. Basic Science on the Cutting Edge
    11. Selected Summaries
    1. Budesonide: Is no evidence of a difference the same as evidence of no difference? (pages 58–59)

      Dr. Lloyd R. Sutherland and S. J. H. van Deventer

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200102000-00009

  6. Section Editor's Commentary

    1. Top of page
    2. Original Contributions
    3. Case Reports
    4. Basic Science Reviews
    5. Review Articles
    6. Controversies in IBD
    7. Section Editor's Commentary
    8. Clinical Viewpoints
    9. Section Editor's Commentary
    10. Basic Science on the Cutting Edge
    11. Selected Summaries
    1. Is budesonide an advance in the treatment of Crohn's disease? (pages 62–63)

      Dr. S. J. H. van Deventer

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200102000-00011

  7. Clinical Viewpoints

    1. Top of page
    2. Original Contributions
    3. Case Reports
    4. Basic Science Reviews
    5. Review Articles
    6. Controversies in IBD
    7. Section Editor's Commentary
    8. Clinical Viewpoints
    9. Section Editor's Commentary
    10. Basic Science on the Cutting Edge
    11. Selected Summaries
    1. The placebo response and the “Natural History” of inflammatory bowel disease (pages 64–66)

      Dr. Henry D. Janowitz, Carol Bodian and David B. Sachar

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200102000-00012

  8. Section Editor's Commentary

    1. Top of page
    2. Original Contributions
    3. Case Reports
    4. Basic Science Reviews
    5. Review Articles
    6. Controversies in IBD
    7. Section Editor's Commentary
    8. Clinical Viewpoints
    9. Section Editor's Commentary
    10. Basic Science on the Cutting Edge
    11. Selected Summaries
    1. IBD and the “uncertainty principle” (page 67)

      David B. Sachar

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200102000-00013

  9. Basic Science on the Cutting Edge

    1. Top of page
    2. Original Contributions
    3. Case Reports
    4. Basic Science Reviews
    5. Review Articles
    6. Controversies in IBD
    7. Section Editor's Commentary
    8. Clinical Viewpoints
    9. Section Editor's Commentary
    10. Basic Science on the Cutting Edge
    11. Selected Summaries
    1. Mechanisms and modulation of intestinal epithelial repair (pages 68–77)

      Dr. Axel U. Dignass

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200102000-00014

  10. Selected Summaries

    1. Top of page
    2. Original Contributions
    3. Case Reports
    4. Basic Science Reviews
    5. Review Articles
    6. Controversies in IBD
    7. Section Editor's Commentary
    8. Clinical Viewpoints
    9. Section Editor's Commentary
    10. Basic Science on the Cutting Edge
    11. Selected Summaries
    1. A shot in the arm for methotrexate (pages 78–79)

      Bruce E. Sands and Russell D. Cohen

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200102000-00015

    2. Support for suppositories (pages 79–80)

      Bruce E. Sands and Lori Kam

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200102000-00016

    3. Stress and gut inflammation: The perception becomes reality (pages 80–81)

      Bruce E. Sands and Judith F. Collins

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200102000-00017

    4. The ABCs of ileal pouch design (page 81)

      Bruce E. Sands and Paul C. Shellito

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200102000-00018

SEARCH

SEARCH BY CITATION